Cargando…

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis

Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half life. This study investigated the efficacy of CERA for correcting anemia in Korean patients on dialysis. Patients (≥18 yr) who were not receiving any ESAs for more than 8 weeks were randomly assigned to either...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Jieun, Joo, Kwon-Wook, Chin, Ho-Jun, Chae, Dong-Wan, Kim, Sung-Gyun, Kim, Soo Jin, Chung, Wookyung, Kim, Sejoong, Huh, Wooseong, Oh, Ha Young, Choi, Bum Soon, Yang, Chul-Woo, Kim, Suhnggwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890480/ https://www.ncbi.nlm.nih.gov/pubmed/24431909 http://dx.doi.org/10.3346/jkms.2014.29.1.76

Ejemplares similares

Predialysis hyponatremia and mortality in elderly patients beginning to undergo hemodialysis
por: Baek, Seon Ha, et al.
Publicado: (2018)

Estimated 24-Hour Urine Sodium Excretion Is Correlated with Blood Pressure in Korean Population: 2009-2011 Korean National Health and Nutritional Examination Survey
por: Oh, Jieun, et al.
Publicado: (2014)

Ribosomal protein mutations in Korean patients with Diamond-Blackfan anemia
por: Chae, Hyojin, et al.
Publicado: (2014)

The association of moderate renal dysfunction with impaired preference-based health-related quality of life: 3(rd )Korean national health and nutritional examination survey
por: Lee, Hajeong, et al.
Publicado: (2012)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis
por: Oh, Se Won, et al.
Publicado: (2013)

Cost-effectiveness of continuous erythropoietin receptor activator in anemia
por: Schmid, Holger
Publicado: (2014)

System of integrating biosignals during hemodialysis: the CONTINUAL (Continuous mOnitoriNg viTal sIgN dUring hemodiALysis) registry
por: Kim, Seonmi, et al.
Publicado: (2022)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
por: Zhu, Yifan, et al.
Publicado: (2022)

Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea
por: Kim, Gheun-Ho, et al.
Publicado: (2014)

An Outbreak of Heinz Body Positive Hemolytic Anemia in Chronic Hemodialysis Patients1
por: Pyo, Heui-Jung, et al.
Publicado: (1993)

Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial
por: Lee, Yeonhee, et al.
Publicado: (2021)

Relationship between Changes in Body Fat and a Decline of Renal Function in the Elderly
por: Oh, Se Won, et al.
Publicado: (2014)

Atherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
por: Chung, Wookyung, et al.
Publicado: (2010)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
por: Munie, Stephanie, et al.
Publicado: (2021)

Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants
por: Hwang, Jin Ho, et al.
Publicado: (2023)

Improvement in Erythropoieis-stimulating Agent-induced Pure Red-cell Aplasia by Introduction of Darbepoetin-α When the Anti-erythropoietin Antibody Titer Declines Spontaneously
por: Lee, Hajeong, et al.
Publicado: (2010)

Small Increases in Plasma Sodium Are Associated with Higher Risk of Mortality in a Healthy Population
por: Oh, Se Won, et al.
Publicado: (2013)

Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
por: Yu, Wei-Hong, et al.
Publicado: (2020)

Vitamin D, and Kidney Disease
por: Kim, Hyung Soo, et al.
Publicado: (2011)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
por: Maoujoud, Omar, et al.
Publicado: (2016)

The effect of depression and health-related quality of life on the outcome of hemodialysis patients()
por: Jeon, Hee Jung, et al.
Publicado: (2012)

Impact of intradialytic hypotension on mortality following the transition from continuous renal replacement therapy to intermittent hemodialysis
por: Kim, Seong Geun, et al.
Publicado: (2023)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Low Resistin Level is Associated with Poor Hospitalization-Free Survival in Hemodialysis Patients
por: Chung, Wookyung, et al.
Publicado: (2012)

Korean clinical practice guidelines for preventing the transmission of infections in hemodialysis facilities
por: Park, Hayne Cho, et al.
Publicado: (2018)

Association of Angiotensin II Type 2 Receptor Gene A1818T Polymorphism with Progression of Immunoglobulin A Nephropathy in Korean Patients
por: Yoon, Hyung Jin, et al.
Publicado: (2009)

Hypochromic red cells as predictors of anemia in patients undergoing hemodialysis: an observational retrospective study
por: Kee, Youn Kyung, et al.
Publicado: (2021)

Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
por: Woo, Hye In, et al.
Publicado: (2017)

Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis: A Pilot Study of Safety and Feasibility
por: Kim, Hyun Young, et al.
Publicado: (2014)

Early Vascular Access Blood Flow as a Predictor of Long-term Vascular Access Patency in Incident Hemodialysis Patients
por: Kim, Hyung Soo, et al.
Publicado: (2010)

Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
por: Rafiean-Kopaie, Mahmoud, et al.
Publicado: (2013)

A Higher Salt Intake Leads to a Lower Rate of Adequate Blood Pressure Control
por: Lee, Jeonghwan, et al.
Publicado: (2014)

Urinary Sodium Excretion Has Positive Correlation with Activation of Urinary Renin Angiotensin System and Reactive Oxygen Species in Hypertensive Chronic Kidney Disease
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
por: Lee, Sung Woo, et al.
Publicado: (2017)

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator
por: Kwon, Hyeok-Jin, et al.
Publicado: (2021)

The Predictive Parameters of Erythropoietin Hyporesponsiveness in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Kim, Jeong Ki, et al.
Publicado: (2001)

Association of serum mineral parameters with mortality in hemodialysis patients: Data from the Korean end-stage renal disease registry
por: Kim, Yunmi, et al.
Publicado: (2018)

Estimating the urinary sodium excretion in patients with chronic kidney disease is not useful in monitoring the effects of a low-salt diet
por: Kim, Se-Yun, et al.
Publicado: (2018)

Mortality of IgA Nephropathy Patients: A Single Center Experience over 30 Years
por: Lee, Hajeong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jitm3o0pk8pacbh3tgev8eiikb